![]() Section 121 of the law permits certain hospitals to be reinstated into the 340B Drug Pricing Program if they meet the following conditions: The Consolidated Appropriations Act of 2022 was signed into law on March 15, 2022. Implementation of Section 121 of the Consolidated Appropriations Act of 2022 This list is in addition to the quarterly MEF posted on the 340B Office of Pharmacy Affairs Information System. HRSA's supplemental Medicaid Exclusion File (MEF) (XLSX - 222 KB) includes a list of entities that have been approved for immediate enrollment. Supplemental Medicaid Exclusion File for immediate registrations ET) or The 340B Prime Vendor will coordinate with HRSA, and each issue will be evaluated on a case-by-case basis. To the extent a 340B stakeholder has a specific circumstance where they believe the end of the PHE may affect their enrollment and compliance in the 340B Program, the stakeholder should contact the 340B Prime Vendor at (Monday - Friday, 9 a.m. ![]() HRSA understands that the end of the PHE may raise questions regarding 340B Program administration and compliance. For audit purposes, entities should continue to maintain accurate records (including their policies and procedures) documenting their compliance with the 340B Program statute and all applicable regulations, guidance, and policies. ![]() Covered entities should continue to comply with the 340B Program statute and all applicable regulations, guidance and policies. Updated 5/11/23: In light of the end of the COVID-19 PHE, the 340B COVID-19 Resources Page has been removed. As such, the specific COVID-19 PHE flexibilities allowed under the 340B Program expired on May 11, 2023. The COVID-19 public health emergency (PHE) ended on May 11, 2023. The COVID-19 public health emergency ended May 11, 2023
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |